HELP     Sign In
Search

Relevance to Autism

Overexpression of the KCTD13 gene in zebrafish resulted in induction of the microcephaly phenotype associated with 16p11.2 duplications, whereas suppression of KCTD13 expression resulted in the macrocephaly phenotype associated with 16p11.2 deletions (Golzio et al., 2012). An autistic proband with a de novo deletion including exons 3-5 of the KCTD13 gene was also identified in this report.

Molecular Function

Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex required for synaptic transmission (PMID 19782033). The BCR(KCTD13) E3 ubiquitin ligase complex mediates the ubiquitination of RHOA, leading to its degradation by the proteasome (PMID 19782033) Degradation of RHOA regulates the actin cytoskeleton and promotes synaptic transmission.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant.
ASD
Support
Epilepsy/seizures
Support
Regulation of purine metabolism connects KCTD13 to a metabolic disorder with autistic features
ASD
SCZ
Support
Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders.
ASD
Support
Identification of rare variants in KCTD13 at the schizophrenia risk locus 16p11.2.
SCZ
Recent Recommendation
Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases.
Recent Recommendation
CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced...
Recent Recommendation
Kctd13 deletion reduces synaptic transmission via increased RhoA.
Recent Recommendation
A Potential Contributory Role for Ciliary Dysfunction in the 16p11.2 600 kb BP4-BP5 Pathology.

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN363R001 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN363R002 
 synonymous_variant 
 c.6G>T 
 p.Ser2= 
 Unknown 
  
  
 GEN363R003 
 missense_variant 
 c.405G>A 
 p.Leu135= 
 Unknown 
 Not maternal 
 Multiplex 
 GEN363R004 
 missense_variant 
 c.256A>C 
 p.Ile86Leu 
 Familial 
  
 Simplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
16
Deletion-Duplication
 151
  construct
16
Duplication
 7
 
16
Deletion
 1
 
16
Deletion
 1
 
16
Duplication
 16
 

Z_KCTD13_5_MRNA_OE_CEP290_MRNA_OE

Rescue Type: RESCUE-Genetic
Rescue Paradigm: 100 pg each of wildtype human KCTD13 and CEP290 transcripts were injected into wild-type zebrafish embryos at the 1- to 2-cell stage.

Z_KCTD13_5_MRNA_OE_CEP290_MRNA_OE

Category
Entity
Effect on phenotype Qualification
Restored Treatment improves measured phenotype significantly
Refractory Treatment does not improve measured phenotype (was expected to do so)
Ameliorated Treatment provides partial correction or improvement of measured phenotype
No adverse effect Treatment does not affect the parameter adversely
Sustained effect Treatment has long term effect of restoration or amelioration, tested AFTER stopping administration (not applied for continuing long-term treatment) . Will be applied only where treatment has had restorative effects during administration or in the first battery of tests conducted.
No sustained effect Treatment has no long term of restoration or amelioration detectable, after stopping administration. Will be applied only where treatment has had restorative effects during administration or in the first battery of tests conducted.
Unexpected results Treats an unexpected phenotype
Side effect Exaggerates an unexpected phenotype
Experimental Paradigm
Age at Testing
Neuronal number1
Ameliorated
Description: Coinjection of kctd13 and cep290 transcripts rescued HuC/D expression compared to embryos injected with kctd13 transcript alone.
Exp Paradigm: Injected embryos were stained with HuC/D antibody. Anti-HuC/D is a marker for post- mitotic neurons, i.e., cells positive for HuC and HuD (also known as ELAVL3 and ELAVL4).
 Immunostaining
 2 dpf
Neuronal number1
Ameliorated
Description: Coinjection of cep290 mRNA and kctd13 mRNA reduced unilateral expression of HuC/D compared to embryos injected with Kctd13 mRNA alone.
Exp Paradigm: Injected embryos were stained with HuC/D antibody. Anti-HuC/D is a marker for post- mitotic neurons, i.e., cells positive for HuC and HuD (also known as ELAVL3 and ELAVL4).
 Immunostaining
 2 dpf
Neuronal number1
Ameliorated
Description: KCTD13 RNA and CEP290 RNA coinjection showed a significant rescue of bilateral HuC/D expression in the forebrain.
Exp Paradigm: Injected embryos were stained with HuC/D antibody. Anti-HuC/D is a marker for post- mitotic neurons, i.e., cells positive for HuC and HuD (also known as ELAVL3 and ELAVL4).
 Immunostaining
 2 dpf
Neuronal number1
No adverse effect
Description: Coinjection of kctd13 transcript and cep290 transcript showed no significant increase in ectopic HuC/D expression compared to embryos injected with kctd13 transcript alone.
Exp Paradigm: Injected embryos were stained with HuC/D antibody. Anti-HuC/D is a marker for post- mitotic neurons, i.e., cells positive for HuC and HuD (also known as ELAVL3 and ELAVL4).
 Immunostaining
 2 dpf
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

Z_KCTD13_3_MRNA_OE

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
 Brain size1
 Decreased
Description: KCTD13 mRNA injected embryos show reduced head size compared to controls.
 Microscopic analysis
 4.5 dpf
 Neuronal number1
 Decreased
Description: KCTD13 mRNA injection shows reduced bilateral HuC/D expression compared to controls.
Exp Paradigm: Injected embryos were stained with HuC/D antibody. Anti-HuC/D is a marker for post- mitotic neurons, i.e., cells positive for HuC and HuD (also known as ELAVL3 and ELAVL4).
 Immunostaining
 2 dpf
 Brain size1
 Decreased
Description: Intraocular distance was decreased in embryos injected with kctd13 transcript compared to controls.
 Microscopic analysis
 4.5 dpf
 Neuronal number1
 Increased
Description: Kctd13 mRNA injection increased unilateral HuC/D expression compared to controls.
Exp Paradigm: Injected embryos were stained with HuC/D antibody. Anti-HuC/D is a marker for post- mitotic neurons, i.e., cells positive for HuC and HuD (also known as ELAVL3 and ELAVL4).
 Immunostaining
 2 dpf
 Neuronal number1
 Decreased
Description: Injection of kctd13 transcript reduced HuC/D expression compared to controls.
Exp Paradigm: Injected embryos were stained with HuC/D antibody. Anti-HuC/D is a marker for post- mitotic neurons, i.e., cells positive for HuC and HuD (also known as ELAVL3 and ELAVL4).
 Immunostaining
 2 dpf
Neuronal number1
 No change
 Immunostaining
 2 dpf
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
ARIH1 ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila) 25820 Q9Y4X5 IP; LC-MS/MS
Huttlin EL , et al. 2015
ARMC7 armadillo repeat containing 7 79637 Q9H6L4 Y2H
Rual JF , et al. 2005
C6orf55 Vps20-associated 1 homolog (S. cerevisiae) 51534 Q9NP79 Y2H
Rual JF , et al. 2005
CUL3 cullin 3 8452 B7Z600 IP; MS; COMPASS
Bennett EJ , et al. 2010
CUL3 cullin 3 8452 B7Z600 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CUL3 cullin 3 8452 B7Z600 Y2H
Lin GN , et al. 2015
CUL3 cullin 3 8452 B7Z600 IP; LC-MS/MS
Huttlin EL , et al. 2015
FLJ22494 nudix (nucleoside diphosphate linked moiety X)-type motif 18 79873 Q6ZVK8 Y2H
Rual JF , et al. 2005
FLNC filamin C, gamma 2318 Q14315 IP; LC-MS/MS
Huttlin EL , et al. 2015
KAT7 K(lysine) acetyltransferase 7 11143 B4DGY4 Y2H
Rual JF , et al. 2005
KCTD10 potassium channel tetramerisation domain containing 10 83892 Q9H3F6 IP; MS; COMPASS
Sowa ME , et al. 2009
KCTD10 potassium channel tetramerisation domain containing 10 83892 Q9H3F6 IP; LC-MS/MS
Huttlin EL , et al. 2015
KCTD13 potassium channel tetramerisation domain containing 13 253980 Q8WZ19 IP; MS; COMPASS
Sowa ME , et al. 2009
KCTD13 potassium channel tetramerisation domain containing 13 253980 Q8WZ19 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
LAMB4 laminin, beta 4 22798 A4D0S4 IP; MS; COMPASS
Sowa ME , et al. 2009
LNX ligand of numb-protein X 1, E3 ubiquitin protein ligase 84708 Q8TBB1 Y2H
Rual JF , et al. 2005
MYST2 K(lysine) acetyltransferase 7 11143 B4DGY4 Y2H
Rual JF , et al. 2005
Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 4790 P19838 Y2H; GST
He H , et al. 2001
NUDT18 nudix (nucleoside diphosphate linked moiety X)-type motif 18 79873 Q6ZVK8 Y2H
Rual JF , et al. 2005
PCNA proliferating cell nuclear antigen 5111 P12004 Y2H
Rual JF , et al. 2005
PFDN2 prefoldin subunit 2 5202 B1AQP2 IP; LC-MS/MS
Huttlin EL , et al. 2015
PLEC plectin 5339 Q15149 IP; MS; COMPASS
Sowa ME , et al. 2009
POLD2 polymerase (DNA directed), delta 2, accessory subunit 5425 A4D2J4 Y2H
Rual JF , et al. 2005
SPRTN SprT-like N-terminal domain 83932 Q9H040 TAP; MS
Ghosal G , et al. 2012
SRPX sushi-repeat containing protein, X-linked 8406 B3KWP8 IP; MS; COMPASS
Sowa ME , et al. 2009
TFAP2A transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) 7020 P05549 Y2H; GST; IP/WB
Ding X , et al. 2008
TNFAIP1 tumor necrosis factor, alpha-induced protein 1 (endothelial) 7126 Q13829 IP; MS; COMPASS
Sowa ME , et al. 2009
TNFAIP1 tumor necrosis factor, alpha-induced protein 1 (endothelial) 7126 Q13829 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TNFAIP1 tumor necrosis factor, alpha-induced protein 1 (endothelial) 7126 Q13829 IP; LC-MS/MS
Huttlin EL , et al. 2015
UBC ubiquitin C 7316 P63279 LC-MS/MS
Danielsen JM , et al. 2010
USP25 ubiquitin specific peptidase 25 29761 Q9UHP3 IP; MS; COMPASS
Sowa ME , et al. 2009
USP25 ubiquitin specific peptidase 25 29761 Q9UHP3 IP; LC-MS/MS
Huttlin EL , et al. 2015
VTA1 Vps20-associated 1 homolog (S. cerevisiae) 51534 Q9NP79 Y2H
Rual JF , et al. 2005
ZMYND19 zinc finger, MYND-type containing 19 116225 Q96E35 Y2H
Rual JF , et al. 2005
ZMYND19 zinc finger, MYND-type containing 19 116225 Q96E35 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CUL3 cullin 3 26554 Q9JLV5 IP/WB
Ibeawuchi SR , et al. 2015
Rnd2 Rho family GTPase 2 11858 Q9QYM5 Y2H; IP/WB
Gladwyn-Ng I , et al. 2016
Rnd3 Rho family GTPase 3 74194 P61588 Y2H; IP/WB
Gladwyn-Ng I , et al. 2016
Sp1 trans-acting transcription factor 1 20683 O89090 Luciferase reporter assay
Zhou J , et al. 2005

HELP
Copyright © 2017 MindSpec, Inc.